
|Articles|June 1, 2001
The American Journal of Managed Care
- June 2001
- Volume 7
- Issue 6
Effect of Rofecoxib Therapy on Measures of Health-Related Quality of Life in Patients with Osteoarthritis
Advertisement
Articles in this issue
over 24 years ago
Does the HEDIS Asthma Measure Go Far Enough?over 24 years ago
Rheumatoid Arthritis: Guidelines for Emerging TherapiesNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Integrated Care for Chronic Conditions: A Randomized Care Management Trial
2
What ACA Subsidy Expiration Means for Coverage Costs, Employer Strategy, and ICHRAs: Q&A With Ben Light
3
It’s Time to Reimagine Reimbursement for CAR T-Cell Therapy
4
Daratumumab Offers Hope for Delaying Progression to Active MM: Peter Voorhees, MD
5













































